Liposomal delivery of CTL epitopes to dendritic cells

Bioscience Reports

Volumn 22, Issue 2, 2002, Pages 339-353

  Chikh, Ghania ^a   Schutze Redelmeir, Marie Paule ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cytotoxic T lymphocyte; Dendritic cells; Liposomes; Vaccine

Indexed keywords

1,2 DIOLEOYLOXY 3 (TRIMETHYLAMMONIO)PROPANE; ANIONIC LIPOSOME; ANTENNAPEDIA PROTEIN; ARCHAEOSOME; CATIONIC LIPOSOME; CD4 ANTIGEN; CD8 ANTIGEN; CHOLESTEROL DERIVATIVE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLPHOSPHATIDYLSERINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; DRUG CARRIER; EPITOPE; FUSOGENIC LIPOSOME; LIPOFECTIN; LIPOSOME; LIVE VACCINE; MACROGOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEUTRAL LIPOSOME; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; TOCOPHEROL DERIVATIVE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; CELL ACTIVATION; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; IMMUNITY; LIPID VESICLE; NONHUMAN; PARASITOSIS; SHORT SURVEY; T LYMPHOCYTE; TUMOR GROWTH; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTENNAPEDIA HOMEODOMAIN PROTEIN; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; ARCHAEA; CATIONS; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEODOMAIN PROTEINS; HUMANS; LIPOSOMES; MEMBRANE FUSION; MEMBRANE LIPIDS; MICE; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; POLYETHYLENE GLYCOLS; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTORS; VACCINATION; VACCINES, SUBUNIT;

EID: 0036555126     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020151025412     Document Type: Short Survey

References (75)

1. Aiba, S. (1998) Maturation of dendritic cells induced by cytokines and haptens. Tohoku J. Exp. Med. 184:159-172.
2. Albert, M. L., Kim, J. I., and Birge, R. B. (2000) alphavbeta5 integrin recruits the CrkII-Dock180-racl complex for phagocytosis of apoptotic cells. Nat. Cell Biol. 2:899-905.
3. Albert, M. L., Sauter, B., and Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
4. Alving, C. R., Koulchin, V., Glenn, G. M., and Rao, M. (1995) Liposomes as carriers of peptide antigens: Induction of antibodies and cytototic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145:5-31.
5. Alving, C. R., and Wassef, N. M. (1994) Cytotoxic T lymphocytes induced by liposomal antigens: Mechanisms of immunological presentation. AIDS Res. Hum. Retroviruses 10:S91-S94.
6. Babu, J. S., Nair, S., Kanda, P., and Rouse, B. T. (1995) Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by actylation units and liposome encapsulation. Vaccine 13:1669-1676.
7. Banchereau, J. and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392:245-252.
8. Bauer, M. V. et al. (2001) Bacterial cpg-dna triggers activation and maturation of human cdllc(-), cd 123(+) dendritic cells. J. Immunol. 166:5000-5007.
9. Bestman-Smith, J., Gourde, P., Desormeaux, A., Tremblay, M. J., and Bergeron, M. G. (2000) Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. Biochim. Biophys. Acta. 1468:161-174.
10. Brunel, F., Darbouret, A., and Ronco, J. (1999) Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine, Vaccine 17:2192-2203.
11. Bui, T., Dykers, T., Hu, S. L., Faltynek, C. R., and Ho, R. J. (1994) Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J. Acquir. Immune Def. Syndr. 7:99-806.
12. Chang, J., Choi, M., Cheong, H., and Kim, K. (2001) Development of Thl-mediated CD8+ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes. Vaccine 19:3608-3614.
13. Chikh, G., Bally, M., and Schutze Redermeier, M. (2001b) Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes. J. Immunol. Methods 254:119-135.
14. Chikh, G., Kong, S., Bally, M., Meunier, J.-C., and Schutze-Redermeir, M. (2001a) Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells. J. Immunol. 167:6462-6470.
15. Conlan, J. W., Krishnan, L., Willick, G. E., Patel, G. B., and Sprott, G. D. (2001) Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes. Vaccine 19:3509-3517.
16. Cox, J. C. and Coulter, A. R. (1997) Adjuvants - A classification and review of their modes of action. Vaccine 15:248-256.
17. Dallal, R. M. and Lotze, M. T. (2000) The dendritic cell and human cancer vaccines. Curr. Opin. Immunol. 12:583-588.
18. Deprez, B. et al. (1996) Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL. Vaccine 5:375-382.
19. Diehl, L. et al. (1999) CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 5:774-779.
20. Fukasawa, M. et al. (1998) Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FEBS Lett. 441:353-356.
21. Gabizon, A., and Papahadjopoulos, D. (1992) The role of surface charge and hydrophilic groups in liposome clearance in vivo. Biochimica Biophysica Acta 1103:94-100.
22. Germain, R. N. (1994) MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287-299.
23. Grossmann, M. E., Davila, E., and Celis, E. (2001) Avoiding tolerance against prostatic antigens with subdominant peptide epitopes. J. Immunother. 24:237-241.
24. Guermonprez, P. et al. (2001) The denylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J. Exp. Med. 193:1035-1044.
25. Gursel, I., Gursel, M., Ishii, K. J., and Klinman, D. M. (2001) Sterically stablized cationic liposomes improve the uptake and immunostimulatory activity of cpg oligonucleotides. J. Immunol. 167:3324-3328.
26. Guy, B. et al. (1998) Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16:850-856.
27. Guy, B. et al. (2001) Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine 19:1794-1805.
28. Harding, C. V., Collins, D. S., Kanagawa, O. and Unanue, E. R. (1991) Liposome-encapsulated antigens engender lyosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147:2860-2863.
29. Holland, J. W., Cullis, P. R., and Madden, T. D. (1996) Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry 35:2610-2617.
30. Ignatius, R. et al. (2000) Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8(+) T-cell responses in vivo. Blood 96:3505-3513.
31. Ishiwata, H., Sato, S. B., Kobayashi, S., Oku, M., Vertut-Doi, A., and Miyajima, K. (1998) Poly(ethylene glycol) derivative of cholesterol reduces binding step of liposome uptake by murine macrophage-like cell line J774 and human hepatoma cell line HepG2. Chem. Pharm. Bull. (Tokyo) 46:1907-1913.
32. Ishiwata, H., Vertut-Doi, A., Hirose, T., and Miyajima, K. (1995) Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesterol ether. Chemical & Pharmaceutical Bulletin 43:1005-1011.
33. Ito, D., Ogasawara, K., Iwabuchi, K., and Onoe, K. (2000) Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb. J. Immunol. 164:1230-1235.
34. Klinman, D. M., Barnhart, K. M., and Conover, J. (1999) CpG motifs as immune adjuvants. Vaccine 17:19-25.
35. Kovacsovics-Bankowski, M. and Rock, K. L. (1995) A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-246.
36. Krishnan, L., Sad, S., Patel, G. B., and Sprott, G. D. (2000) Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. J. Immunol. 165:5177-5185.
37. Krishnan, L., Sad, S., Patel, G. B., and Sprott, G. D. (2001) The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J. Immunol. 166:1885-1893.
38. Kwak, L. W., Pennington, R., Boni, L., Ochoa, A. C., Robb, R. C., and Popescu, J. M. C. (1998) Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. J. Immunol. 160:3637-41.
39. Lasic, D. D., Martin, F. J., Gabizon, A., Huang, S. K. and Papahadjopoulos, D. (1991) Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochimica Biophysica Acta 1070:187-192.
40. Lee, K. D., Oh, Y. K., Portnoy, D. A., and Swanson, J. A. (1996) Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J. Biol. Chem. 271:7249-7252.
41. Loing, E. et al. (2000) Extension of HLA-A*0201 restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells. J. Immunol. 164:900-907.
42. Ludewig, B., Barchiesi, F., Pericin, M., Zinkernagel, R. M., Hengartner, H., and Schwendener, R. A. (2000) In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumor immunity. Vaccine 19:23-32.
43. Lynch, D. H. (1998) Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo. Crit. Rev. Immunol. 18:99-107.
44. Machy, P., Serre, K., Leserman, L. (2000) Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30:848-857.
45. Mayordomo, J. I., et al. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297-1302.
46. Mizuguchi, H., Nakagawa, T., Nakanishi, M., Imazu, S., Nakagawa, S., and Mayumi, T. (1996) Efficient gene transfer into mammalian cells using fusogenic liposome. Biochem. Biophys. Res. Commun. 218:402-407.
47. Moore, M. W., Carbone, F. R., and Bevan, M. J. (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-785.
48. Mora, A. L. and Tam, J. P. (1998) Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations. J. Immunol. 161:3616-3623.
49. Morse, M. A. (2001) Technology evaluation: BLP-25, Biomira Inc. Curr. Opin. Mol. Ther. 3:102-105.
50. Mulders, P. et al. (1999) Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines. Clin. Cancer Res. 5:445-454.
51. Nair, S., Babu, J. S., Dunham, R. G., Kanda, P., Burke, R. L., and Rouse, B. T. (1993) Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J. Virol. 67:4062-4069.
52. Nair, S., Zhou, F., Reddy, R., Huang, L., and Rouse, B. T. (1992) Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175:609-612.
53. Nakanishi, T. et al. (2000) Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway [In Process Citation]. Eur. J. Immunol. 30:1740-1747.
54. Nakanishi, T. et al. (1997) Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 240:793-797.
55. Nakanishi, T. et al. (1999) Positive-charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J. Control Release 61:233.
56. Nestle, F. O. et al. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [see comments]. Nat. Med. 4:328-332.
57. Norbury, C. C., Chambers, B. J., Prescott, A. R., Ljunggren, H. G. and Watts, C. (1997) Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280-288.
58. Okada, N. et al. (2001) Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation. Biochim. Biophys. Acta 1527:97-101.
59. Piemonti, L. P. et al. (1999) Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162:6473-6481.
60. Pisarev, V. M. et al. (2000) Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine. Int. J. Immunopharmacol 22:865-876.
61. Reddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M., and Rouse, B. T. (1991) pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted Ctl recognition of a soluble protein. J. Immunol. Methods 141:157-163.
62. Richards, R. L., Rao, M., Wassef, N. M., Glenn, G. M., Rothwell, S. W., and Alving, C. R. (1998) Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTSS malaria antigen. Infect. Immun. 66:2859-2865.
63. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S. (1999) Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells [see comments]. Natl. Cell Biol. 1:362-368.
64. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995) Dendritic cells used macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
65. Sasaki, S. et al. (1997) Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27:3121-3129.
66. Schutze-Redelmeir, M. P. et al. (1996) Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. 157:650-655.
67. Serre, K. et al. (1998) Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells. J. Immunol. 161:6059-6067.
68. Tarte, K. and Klein, B. (1999) Dendritic cell-based vaccine: A promising approach for cancer immunotherapy. Leukemia 13:653-663.
69. Terheyden, P., Straten, P., Brocker, E. B., Kampgen, E., and Becker, J. C. (2000) CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes. J. Immunol. 164:6633-6639.
70. Toda, S. et al. (1997) HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology 92:111-117.
71. Toes, R. E. et al. (1998) Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J. Immunol. 160:4449-4456.
72. White, W. I. et al. (1995) Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 13:1111-1122.
73. Zheng, L., Huang, X. L., Fan, Z., Borowski, L., Wilson, C. C., and Rinaldo, C. R., Jr. (1999) Delivery of liposome-encapsulated HIV type I proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses. AIDS Res. Hum. Retroviruses 15:1011-1020.
74. Zhou, F., Rouse, B. T., and Huang, L. (1992) Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: A model study. Cancer Res. 52:6287-6291.
75. Zhou, F., Watkins, S. C., and Huang, L. (1994) Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes. Immunobiology 190:35-52.